Plain-English translation of NCT04822077 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing proton radiotherapy—a specialized form of radiation treatment that targets tumors in the thymus gland (an organ in your chest) with high precision. Unlike standard radiation, proton therapy delivers its dose directly to the tumor and stops, potentially sparing nearby healthy tissues like the heart and lungs. The goal is to treat thymus cancers effectively while reducing the risk of long-term heart and lung damage.
Thymus gland cancers often require radiation after surgery, but traditional radiation can damage the heart and lungs over time. This treatment aims to deliver radiation more precisely to kill cancer cells while protecting your vital organs and reducing the risk of serious long-term side effects.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive proton radiation therapy on an outpatient basis (meaning you come in for treatment but do not stay overnight). You will receive daily radiation sessions, five days a week, for several weeks. The exact dose and duration depend on your specific situation—whether you had surgery, how much cancer remains, and the type of cancer. You may also receive chemotherapy before or after radiation, depending on your doctor's recommendation, but not at the same time as radiation. Throughout treatment, your doctors will monitor you for any side effects.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
Sweden